Yong Li

发表

Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents.

Duane D. Miller, S. White, Wei Li, 2021, Journal of medicinal chemistry.

Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.

Duane D. Miller, Wei Li, F. Liao, 2021, ACS medicinal chemistry letters.

Ag distribution and corrosion behaviour of the plasma electrolytic oxidized antibacterial Mg-Ag alloy

Z. Dong, Yupeng Zhang, Xinxin Zhang, 2022, Electrochimica Acta.

MODL-06. Targeting c-MET in combination with radiation is effective in MET-fusion driven high-grade glioma

Nathaniel R. Twarog, David C. Jones, S. Pfister, 2022, Neuro-Oncology.

High-purity enrichment of functional cardiovascular cells from human iPS cells.

G. Salama, Xonia Carvajal-Vergara, T. Cheng, 2012, Cardiovascular research.

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs.

M. Roussel, Taosheng Chen, A. Shelat, 2021, Angewandte Chemie.

Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design.

Shondra M. Pruett-Miller, R. Heath, Jun J. Yang, 2023, ACS medicinal chemistry letters.

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

M. Roussel, C. Mullighan, M. Fischer, 2021, Journal of Medicinal Chemistry.

X-Ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors.

Duane D. Miller, Wei Li, Weimin Li, 2019, ACS chemical biology.

Ureadepsipeptides as ClpP Activators.

K. Lewis, B. Conlon, W. Shadrick, 2019, ACS infectious diseases.

From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors.

M. Roussel, J. Klco, Lei Yang, 2023, European journal of medicinal chemistry.